nodes	percent_of_prediction	percent_of_DWPC	metapath
Brimonidine—AOX1—myometrium—uterine cancer	0.0157	0.0676	CbGeAlD
Brimonidine—AOX1—uterine cervix—uterine cancer	0.0122	0.0526	CbGeAlD
Brimonidine—AOX1—decidua—uterine cancer	0.0116	0.0502	CbGeAlD
Brimonidine—AOX1—renal system—uterine cancer	0.0114	0.0492	CbGeAlD
Brimonidine—AOX1—endometrium—uterine cancer	0.011	0.0476	CbGeAlD
Brimonidine—AOX1—mammalian vulva—uterine cancer	0.0107	0.0461	CbGeAlD
Brimonidine—AOX1—uterus—uterine cancer	0.0102	0.0439	CbGeAlD
Brimonidine—ADRA2C—myometrium—uterine cancer	0.00991	0.0428	CbGeAlD
Brimonidine—AOX1—female reproductive system—uterine cancer	0.00914	0.0394	CbGeAlD
Brimonidine—AOX1—female gonad—uterine cancer	0.00831	0.0359	CbGeAlD
Brimonidine—AOX1—vagina—uterine cancer	0.00826	0.0357	CbGeAlD
Brimonidine—ADRA2A—myometrium—uterine cancer	0.0079	0.0341	CbGeAlD
Brimonidine—ADRA2C—uterine cervix—uterine cancer	0.00771	0.0333	CbGeAlD
Brimonidine—ADRA2C—decidua—uterine cancer	0.00734	0.0317	CbGeAlD
Brimonidine—ADRA2C—renal system—uterine cancer	0.00721	0.0311	CbGeAlD
Brimonidine—ADRA2C—endometrium—uterine cancer	0.00697	0.0301	CbGeAlD
Brimonidine—ADRA2C—mammalian vulva—uterine cancer	0.00674	0.0291	CbGeAlD
Brimonidine—ADRA2C—uterus—uterine cancer	0.00642	0.0277	CbGeAlD
Brimonidine—ADRA2A—uterine cervix—uterine cancer	0.00615	0.0266	CbGeAlD
Brimonidine—ADRA2A—decidua—uterine cancer	0.00586	0.0253	CbGeAlD
Brimonidine—ADRA2A—endometrium—uterine cancer	0.00556	0.024	CbGeAlD
Brimonidine—ADRA2A—mammalian vulva—uterine cancer	0.00538	0.0232	CbGeAlD
Brimonidine—AOX1—lymph node—uterine cancer	0.00534	0.0231	CbGeAlD
Brimonidine—ADRA2C—female gonad—uterine cancer	0.00526	0.0227	CbGeAlD
Brimonidine—ADRA2C—vagina—uterine cancer	0.00522	0.0225	CbGeAlD
Brimonidine—ADRA2A—uterus—uterine cancer	0.00513	0.0221	CbGeAlD
Brimonidine—ADRA2A—female reproductive system—uterine cancer	0.00461	0.0199	CbGeAlD
Brimonidine—ADRA2A—female gonad—uterine cancer	0.00419	0.0181	CbGeAlD
Brimonidine—ADRA2A—vagina—uterine cancer	0.00417	0.018	CbGeAlD
Brimonidine—ADRA2C—lymph node—uterine cancer	0.00338	0.0146	CbGeAlD
Brimonidine—Feeling hot—Epirubicin—uterine cancer	0.00299	0.00389	CcSEcCtD
Brimonidine—Dry mouth—Progesterone—uterine cancer	0.00298	0.00388	CcSEcCtD
Brimonidine—Oedema—Progesterone—uterine cancer	0.00292	0.0038	CcSEcCtD
Brimonidine—Syncope—Medroxyprogesterone Acetate—uterine cancer	0.00291	0.00379	CcSEcCtD
Brimonidine—Infection—Progesterone—uterine cancer	0.0029	0.00378	CcSEcCtD
Brimonidine—Stinging—Epirubicin—uterine cancer	0.0029	0.00377	CcSEcCtD
Brimonidine—Pharyngitis—Dactinomycin—uterine cancer	0.00289	0.00375	CcSEcCtD
Brimonidine—Shock—Progesterone—uterine cancer	0.00287	0.00374	CcSEcCtD
Brimonidine—Palpitations—Medroxyprogesterone Acetate—uterine cancer	0.00287	0.00373	CcSEcCtD
Brimonidine—Nervous system disorder—Progesterone—uterine cancer	0.00287	0.00373	CcSEcCtD
Brimonidine—Scotoma—Doxorubicin—uterine cancer	0.00286	0.00372	CcSEcCtD
Brimonidine—Tachycardia—Progesterone—uterine cancer	0.00285	0.00371	CcSEcCtD
Brimonidine—Loss of consciousness—Medroxyprogesterone Acetate—uterine cancer	0.00285	0.00371	CcSEcCtD
Brimonidine—Skin disorder—Progesterone—uterine cancer	0.00284	0.00369	CcSEcCtD
Brimonidine—Feeling hot—Doxorubicin—uterine cancer	0.00277	0.0036	CcSEcCtD
Brimonidine—Arthralgia—Medroxyprogesterone Acetate—uterine cancer	0.00276	0.00359	CcSEcCtD
Brimonidine—Chest pain—Medroxyprogesterone Acetate—uterine cancer	0.00276	0.00359	CcSEcCtD
Brimonidine—Myalgia—Medroxyprogesterone Acetate—uterine cancer	0.00276	0.00359	CcSEcCtD
Brimonidine—Anxiety—Medroxyprogesterone Acetate—uterine cancer	0.00275	0.00358	CcSEcCtD
Brimonidine—Unspecified disorder of skin and subcutaneous tissue—Medroxyprogesterone Acetate—uterine cancer	0.00274	0.00357	CcSEcCtD
Brimonidine—Hypotension—Progesterone—uterine cancer	0.00273	0.00355	CcSEcCtD
Brimonidine—Discomfort—Medroxyprogesterone Acetate—uterine cancer	0.00273	0.00355	CcSEcCtD
Brimonidine—Dry mouth—Medroxyprogesterone Acetate—uterine cancer	0.0027	0.00352	CcSEcCtD
Brimonidine—Flushing—Dactinomycin—uterine cancer	0.0027	0.00351	CcSEcCtD
Brimonidine—ADRA2A—lymph node—uterine cancer	0.0027	0.0116	CbGeAlD
Brimonidine—Stinging—Doxorubicin—uterine cancer	0.00268	0.00349	CcSEcCtD
Brimonidine—Vasodilation procedure—Epirubicin—uterine cancer	0.00267	0.00348	CcSEcCtD
Brimonidine—Vasodilation—Epirubicin—uterine cancer	0.00267	0.00348	CcSEcCtD
Brimonidine—Musculoskeletal discomfort—Progesterone—uterine cancer	0.00266	0.00346	CcSEcCtD
Brimonidine—Oedema—Medroxyprogesterone Acetate—uterine cancer	0.00265	0.00345	CcSEcCtD
Brimonidine—Insomnia—Progesterone—uterine cancer	0.00264	0.00344	CcSEcCtD
Brimonidine—Infection—Medroxyprogesterone Acetate—uterine cancer	0.00263	0.00342	CcSEcCtD
Brimonidine—Paraesthesia—Progesterone—uterine cancer	0.00262	0.00341	CcSEcCtD
Brimonidine—Dyspnoea—Progesterone—uterine cancer	0.00261	0.00339	CcSEcCtD
Brimonidine—Shock—Medroxyprogesterone Acetate—uterine cancer	0.0026	0.00339	CcSEcCtD
Brimonidine—Somnolence—Progesterone—uterine cancer	0.0026	0.00338	CcSEcCtD
Brimonidine—Nervous system disorder—Medroxyprogesterone Acetate—uterine cancer	0.0026	0.00338	CcSEcCtD
Brimonidine—Tachycardia—Medroxyprogesterone Acetate—uterine cancer	0.00258	0.00336	CcSEcCtD
Brimonidine—Arthropathy—Epirubicin—uterine cancer	0.00258	0.00336	CcSEcCtD
Brimonidine—Dyspepsia—Progesterone—uterine cancer	0.00257	0.00335	CcSEcCtD
Brimonidine—Skin disorder—Medroxyprogesterone Acetate—uterine cancer	0.00257	0.00335	CcSEcCtD
Brimonidine—Lacrimation increased—Epirubicin—uterine cancer	0.00255	0.00332	CcSEcCtD
Brimonidine—Erythema—Dactinomycin—uterine cancer	0.00253	0.00329	CcSEcCtD
Brimonidine—Gastrointestinal disorder—Progesterone—uterine cancer	0.00252	0.00328	CcSEcCtD
Brimonidine—Fatigue—Progesterone—uterine cancer	0.00252	0.00328	CcSEcCtD
Brimonidine—Pain—Progesterone—uterine cancer	0.0025	0.00325	CcSEcCtD
Brimonidine—Hypotension—Medroxyprogesterone Acetate—uterine cancer	0.00247	0.00322	CcSEcCtD
Brimonidine—Vasodilation procedure—Doxorubicin—uterine cancer	0.00247	0.00322	CcSEcCtD
Brimonidine—Vasodilation—Doxorubicin—uterine cancer	0.00247	0.00322	CcSEcCtD
Brimonidine—Musculoskeletal discomfort—Medroxyprogesterone Acetate—uterine cancer	0.00241	0.00314	CcSEcCtD
Brimonidine—Insomnia—Medroxyprogesterone Acetate—uterine cancer	0.00239	0.00312	CcSEcCtD
Brimonidine—Arthropathy—Doxorubicin—uterine cancer	0.00239	0.00311	CcSEcCtD
Brimonidine—Paraesthesia—Medroxyprogesterone Acetate—uterine cancer	0.00238	0.00309	CcSEcCtD
Brimonidine—Dyspnoea—Medroxyprogesterone Acetate—uterine cancer	0.00236	0.00307	CcSEcCtD
Brimonidine—Lacrimation increased—Doxorubicin—uterine cancer	0.00236	0.00307	CcSEcCtD
Brimonidine—Somnolence—Medroxyprogesterone Acetate—uterine cancer	0.00235	0.00306	CcSEcCtD
Brimonidine—Dyspepsia—Medroxyprogesterone Acetate—uterine cancer	0.00233	0.00303	CcSEcCtD
Brimonidine—Dermatitis contact—Epirubicin—uterine cancer	0.00232	0.00302	CcSEcCtD
Brimonidine—Gastrointestinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.00229	0.00298	CcSEcCtD
Brimonidine—Fatigue—Medroxyprogesterone Acetate—uterine cancer	0.00228	0.00297	CcSEcCtD
Brimonidine—Dry eye—Epirubicin—uterine cancer	0.00217	0.00282	CcSEcCtD
Brimonidine—Myalgia—Dactinomycin—uterine cancer	0.00215	0.0028	CcSEcCtD
Brimonidine—Hypersensitivity—Progesterone—uterine cancer	0.00215	0.0028	CcSEcCtD
Brimonidine—Dermatitis contact—Doxorubicin—uterine cancer	0.00215	0.00279	CcSEcCtD
Brimonidine—Coma—Epirubicin—uterine cancer	0.00215	0.00279	CcSEcCtD
Brimonidine—Discomfort—Dactinomycin—uterine cancer	0.00213	0.00277	CcSEcCtD
Brimonidine—Asthenia—Progesterone—uterine cancer	0.0021	0.00273	CcSEcCtD
Brimonidine—Pruritus—Progesterone—uterine cancer	0.00207	0.00269	CcSEcCtD
Brimonidine—Oedema—Dactinomycin—uterine cancer	0.00207	0.00269	CcSEcCtD
Brimonidine—Infection—Dactinomycin—uterine cancer	0.00205	0.00267	CcSEcCtD
Brimonidine—Abnormal vision—Epirubicin—uterine cancer	0.00205	0.00267	CcSEcCtD
Brimonidine—Dry eye—Doxorubicin—uterine cancer	0.00201	0.00261	CcSEcCtD
Brimonidine—Coma—Doxorubicin—uterine cancer	0.00199	0.00258	CcSEcCtD
Brimonidine—Eye disorder—Etoposide—uterine cancer	0.00197	0.00256	CcSEcCtD
Brimonidine—Diabetes mellitus—Epirubicin—uterine cancer	0.00196	0.00255	CcSEcCtD
Brimonidine—Cardiac disorder—Etoposide—uterine cancer	0.00195	0.00254	CcSEcCtD
Brimonidine—Flushing—Etoposide—uterine cancer	0.00195	0.00254	CcSEcCtD
Brimonidine—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.00195	0.00254	CcSEcCtD
Brimonidine—Dizziness—Progesterone—uterine cancer	0.00193	0.00251	CcSEcCtD
Brimonidine—Angiopathy—Etoposide—uterine cancer	0.00191	0.00248	CcSEcCtD
Brimonidine—Immune system disorder—Etoposide—uterine cancer	0.0019	0.00247	CcSEcCtD
Brimonidine—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.0019	0.00247	CcSEcCtD
Brimonidine—Mediastinal disorder—Etoposide—uterine cancer	0.0019	0.00247	CcSEcCtD
Brimonidine—Abnormal vision—Doxorubicin—uterine cancer	0.0019	0.00247	CcSEcCtD
Brimonidine—Eye pain—Epirubicin—uterine cancer	0.00189	0.00246	CcSEcCtD
Brimonidine—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.00188	0.00245	CcSEcCtD
Brimonidine—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.00187	0.00244	CcSEcCtD
Brimonidine—Rash—Progesterone—uterine cancer	0.00184	0.0024	CcSEcCtD
Brimonidine—Dermatitis—Progesterone—uterine cancer	0.00184	0.0024	CcSEcCtD
Brimonidine—Headache—Progesterone—uterine cancer	0.00183	0.00238	CcSEcCtD
Brimonidine—Diabetes mellitus—Doxorubicin—uterine cancer	0.00181	0.00236	CcSEcCtD
Brimonidine—Dysgeusia—Etoposide—uterine cancer	0.00179	0.00233	CcSEcCtD
Brimonidine—Fatigue—Dactinomycin—uterine cancer	0.00178	0.00232	CcSEcCtD
Brimonidine—Pain—Dactinomycin—uterine cancer	0.00177	0.0023	CcSEcCtD
Brimonidine—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.00175	0.00228	CcSEcCtD
Brimonidine—Eye pain—Doxorubicin—uterine cancer	0.00175	0.00227	CcSEcCtD
Brimonidine—Lethargy—Epirubicin—uterine cancer	0.00174	0.00226	CcSEcCtD
Brimonidine—Nausea—Progesterone—uterine cancer	0.00174	0.00226	CcSEcCtD
Brimonidine—Osteoarthritis—Epirubicin—uterine cancer	0.0017	0.00222	CcSEcCtD
Brimonidine—Rash—Medroxyprogesterone Acetate—uterine cancer	0.00167	0.00217	CcSEcCtD
Brimonidine—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.00167	0.00217	CcSEcCtD
Brimonidine—Headache—Medroxyprogesterone Acetate—uterine cancer	0.00166	0.00216	CcSEcCtD
Brimonidine—Face oedema—Epirubicin—uterine cancer	0.00165	0.00214	CcSEcCtD
Brimonidine—Loss of consciousness—Etoposide—uterine cancer	0.00161	0.0021	CcSEcCtD
Brimonidine—Lethargy—Doxorubicin—uterine cancer	0.00161	0.00209	CcSEcCtD
Brimonidine—Cough—Etoposide—uterine cancer	0.0016	0.00208	CcSEcCtD
Brimonidine—Hypertension—Etoposide—uterine cancer	0.00158	0.00206	CcSEcCtD
Brimonidine—Osteoarthritis—Doxorubicin—uterine cancer	0.00158	0.00205	CcSEcCtD
Brimonidine—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.00157	0.00205	CcSEcCtD
Brimonidine—Dry skin—Epirubicin—uterine cancer	0.00156	0.00203	CcSEcCtD
Brimonidine—Chest pain—Etoposide—uterine cancer	0.00156	0.00203	CcSEcCtD
Brimonidine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.00155	0.00202	CcSEcCtD
Brimonidine—Discomfort—Etoposide—uterine cancer	0.00154	0.00201	CcSEcCtD
Brimonidine—Nasopharyngitis—Epirubicin—uterine cancer	0.00152	0.00198	CcSEcCtD
Brimonidine—Face oedema—Doxorubicin—uterine cancer	0.00152	0.00198	CcSEcCtD
Brimonidine—Hypersensitivity—Dactinomycin—uterine cancer	0.00152	0.00198	CcSEcCtD
Brimonidine—Infection—Etoposide—uterine cancer	0.00148	0.00193	CcSEcCtD
Brimonidine—Asthenia—Dactinomycin—uterine cancer	0.00148	0.00193	CcSEcCtD
Brimonidine—Influenza—Epirubicin—uterine cancer	0.00147	0.00192	CcSEcCtD
Brimonidine—Tachycardia—Etoposide—uterine cancer	0.00146	0.0019	CcSEcCtD
Brimonidine—Skin disorder—Etoposide—uterine cancer	0.00145	0.00189	CcSEcCtD
Brimonidine—Dry skin—Doxorubicin—uterine cancer	0.00145	0.00188	CcSEcCtD
Brimonidine—Bronchitis—Epirubicin—uterine cancer	0.00142	0.00184	CcSEcCtD
Brimonidine—Nasopharyngitis—Doxorubicin—uterine cancer	0.00141	0.00184	CcSEcCtD
Brimonidine—Hypotension—Etoposide—uterine cancer	0.0014	0.00182	CcSEcCtD
Brimonidine—Influenza—Doxorubicin—uterine cancer	0.00136	0.00177	CcSEcCtD
Brimonidine—Paraesthesia—Etoposide—uterine cancer	0.00134	0.00175	CcSEcCtD
Brimonidine—Dyspnoea—Etoposide—uterine cancer	0.00133	0.00173	CcSEcCtD
Brimonidine—Somnolence—Etoposide—uterine cancer	0.00133	0.00173	CcSEcCtD
Brimonidine—Drowsiness—Epirubicin—uterine cancer	0.00131	0.00171	CcSEcCtD
Brimonidine—Bronchitis—Doxorubicin—uterine cancer	0.00131	0.00171	CcSEcCtD
Brimonidine—Rash—Dactinomycin—uterine cancer	0.0013	0.00169	CcSEcCtD
Brimonidine—Gastrointestinal disorder—Etoposide—uterine cancer	0.00129	0.00168	CcSEcCtD
Brimonidine—Fatigue—Etoposide—uterine cancer	0.00129	0.00168	CcSEcCtD
Brimonidine—Pain—Etoposide—uterine cancer	0.00128	0.00166	CcSEcCtD
Brimonidine—Conjunctivitis—Epirubicin—uterine cancer	0.00128	0.00166	CcSEcCtD
Brimonidine—Sinusitis—Epirubicin—uterine cancer	0.00123	0.0016	CcSEcCtD
Brimonidine—Nausea—Dactinomycin—uterine cancer	0.00123	0.0016	CcSEcCtD
Brimonidine—Drowsiness—Doxorubicin—uterine cancer	0.00122	0.00158	CcSEcCtD
Brimonidine—Bradycardia—Epirubicin—uterine cancer	0.0012	0.00156	CcSEcCtD
Brimonidine—Rhinitis—Epirubicin—uterine cancer	0.00118	0.00154	CcSEcCtD
Brimonidine—Conjunctivitis—Doxorubicin—uterine cancer	0.00118	0.00154	CcSEcCtD
Brimonidine—Pharyngitis—Epirubicin—uterine cancer	0.00117	0.00152	CcSEcCtD
Brimonidine—Sinusitis—Doxorubicin—uterine cancer	0.00114	0.00148	CcSEcCtD
Brimonidine—Visual impairment—Epirubicin—uterine cancer	0.00114	0.00148	CcSEcCtD
Brimonidine—Bradycardia—Doxorubicin—uterine cancer	0.00111	0.00145	CcSEcCtD
Brimonidine—Eye disorder—Epirubicin—uterine cancer	0.0011	0.00143	CcSEcCtD
Brimonidine—Hypersensitivity—Etoposide—uterine cancer	0.0011	0.00143	CcSEcCtD
Brimonidine—Cardiac disorder—Epirubicin—uterine cancer	0.00109	0.00142	CcSEcCtD
Brimonidine—Flushing—Epirubicin—uterine cancer	0.00109	0.00142	CcSEcCtD
Brimonidine—Rhinitis—Doxorubicin—uterine cancer	0.00109	0.00142	CcSEcCtD
Brimonidine—Pharyngitis—Doxorubicin—uterine cancer	0.00108	0.00141	CcSEcCtD
Brimonidine—Asthenia—Etoposide—uterine cancer	0.00107	0.0014	CcSEcCtD
Brimonidine—Angiopathy—Epirubicin—uterine cancer	0.00107	0.00139	CcSEcCtD
Brimonidine—Immune system disorder—Epirubicin—uterine cancer	0.00107	0.00139	CcSEcCtD
Brimonidine—Mediastinal disorder—Epirubicin—uterine cancer	0.00106	0.00138	CcSEcCtD
Brimonidine—Pruritus—Etoposide—uterine cancer	0.00106	0.00138	CcSEcCtD
Brimonidine—Arrhythmia—Epirubicin—uterine cancer	0.00105	0.00137	CcSEcCtD
Brimonidine—Visual impairment—Doxorubicin—uterine cancer	0.00105	0.00137	CcSEcCtD
Brimonidine—Mental disorder—Epirubicin—uterine cancer	0.00103	0.00134	CcSEcCtD
Brimonidine—Erythema—Epirubicin—uterine cancer	0.00103	0.00134	CcSEcCtD
Brimonidine—Eye disorder—Doxorubicin—uterine cancer	0.00102	0.00133	CcSEcCtD
Brimonidine—Cardiac disorder—Doxorubicin—uterine cancer	0.00101	0.00132	CcSEcCtD
Brimonidine—Flushing—Doxorubicin—uterine cancer	0.00101	0.00132	CcSEcCtD
Brimonidine—Dysgeusia—Epirubicin—uterine cancer	0.00101	0.00131	CcSEcCtD
Brimonidine—Angiopathy—Doxorubicin—uterine cancer	0.00099	0.00129	CcSEcCtD
Brimonidine—Dizziness—Etoposide—uterine cancer	0.000988	0.00129	CcSEcCtD
Brimonidine—Immune system disorder—Doxorubicin—uterine cancer	0.000986	0.00128	CcSEcCtD
Brimonidine—Mediastinal disorder—Doxorubicin—uterine cancer	0.000983	0.00128	CcSEcCtD
Brimonidine—Arrhythmia—Doxorubicin—uterine cancer	0.000975	0.00127	CcSEcCtD
Brimonidine—Vision blurred—Epirubicin—uterine cancer	0.000968	0.00126	CcSEcCtD
Brimonidine—Mental disorder—Doxorubicin—uterine cancer	0.000956	0.00124	CcSEcCtD
Brimonidine—Erythema—Doxorubicin—uterine cancer	0.00095	0.00124	CcSEcCtD
Brimonidine—Rash—Etoposide—uterine cancer	0.000942	0.00123	CcSEcCtD
Brimonidine—Dermatitis—Etoposide—uterine cancer	0.000942	0.00123	CcSEcCtD
Brimonidine—Headache—Etoposide—uterine cancer	0.000936	0.00122	CcSEcCtD
Brimonidine—Dysgeusia—Doxorubicin—uterine cancer	0.00093	0.00121	CcSEcCtD
Brimonidine—Syncope—Epirubicin—uterine cancer	0.000921	0.0012	CcSEcCtD
Brimonidine—Palpitations—Epirubicin—uterine cancer	0.000907	0.00118	CcSEcCtD
Brimonidine—Loss of consciousness—Epirubicin—uterine cancer	0.000902	0.00117	CcSEcCtD
Brimonidine—Cough—Epirubicin—uterine cancer	0.000896	0.00117	CcSEcCtD
Brimonidine—Vision blurred—Doxorubicin—uterine cancer	0.000895	0.00117	CcSEcCtD
Brimonidine—Nausea—Etoposide—uterine cancer	0.000888	0.00116	CcSEcCtD
Brimonidine—Hypertension—Epirubicin—uterine cancer	0.000886	0.00115	CcSEcCtD
Brimonidine—Myalgia—Epirubicin—uterine cancer	0.000874	0.00114	CcSEcCtD
Brimonidine—Arthralgia—Epirubicin—uterine cancer	0.000874	0.00114	CcSEcCtD
Brimonidine—Chest pain—Epirubicin—uterine cancer	0.000874	0.00114	CcSEcCtD
Brimonidine—Anxiety—Epirubicin—uterine cancer	0.000871	0.00113	CcSEcCtD
Brimonidine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.000868	0.00113	CcSEcCtD
Brimonidine—Discomfort—Epirubicin—uterine cancer	0.000864	0.00112	CcSEcCtD
Brimonidine—Dry mouth—Epirubicin—uterine cancer	0.000855	0.00111	CcSEcCtD
Brimonidine—Syncope—Doxorubicin—uterine cancer	0.000852	0.00111	CcSEcCtD
Brimonidine—Palpitations—Doxorubicin—uterine cancer	0.000839	0.00109	CcSEcCtD
Brimonidine—Oedema—Epirubicin—uterine cancer	0.000838	0.00109	CcSEcCtD
Brimonidine—Loss of consciousness—Doxorubicin—uterine cancer	0.000835	0.00109	CcSEcCtD
Brimonidine—Infection—Epirubicin—uterine cancer	0.000832	0.00108	CcSEcCtD
Brimonidine—Cough—Doxorubicin—uterine cancer	0.000829	0.00108	CcSEcCtD
Brimonidine—Shock—Epirubicin—uterine cancer	0.000824	0.00107	CcSEcCtD
Brimonidine—Nervous system disorder—Epirubicin—uterine cancer	0.000822	0.00107	CcSEcCtD
Brimonidine—Hypertension—Doxorubicin—uterine cancer	0.00082	0.00107	CcSEcCtD
Brimonidine—Tachycardia—Epirubicin—uterine cancer	0.000818	0.00106	CcSEcCtD
Brimonidine—Skin disorder—Epirubicin—uterine cancer	0.000814	0.00106	CcSEcCtD
Brimonidine—Myalgia—Doxorubicin—uterine cancer	0.000809	0.00105	CcSEcCtD
Brimonidine—Chest pain—Doxorubicin—uterine cancer	0.000809	0.00105	CcSEcCtD
Brimonidine—Arthralgia—Doxorubicin—uterine cancer	0.000809	0.00105	CcSEcCtD
Brimonidine—Anxiety—Doxorubicin—uterine cancer	0.000806	0.00105	CcSEcCtD
Brimonidine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.000803	0.00105	CcSEcCtD
Brimonidine—Discomfort—Doxorubicin—uterine cancer	0.000799	0.00104	CcSEcCtD
Brimonidine—Dry mouth—Doxorubicin—uterine cancer	0.000791	0.00103	CcSEcCtD
Brimonidine—Hypotension—Epirubicin—uterine cancer	0.000783	0.00102	CcSEcCtD
Brimonidine—Oedema—Doxorubicin—uterine cancer	0.000775	0.00101	CcSEcCtD
Brimonidine—Infection—Doxorubicin—uterine cancer	0.00077	0.001	CcSEcCtD
Brimonidine—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000763	0.000994	CcSEcCtD
Brimonidine—Shock—Doxorubicin—uterine cancer	0.000763	0.000993	CcSEcCtD
Brimonidine—Nervous system disorder—Doxorubicin—uterine cancer	0.00076	0.00099	CcSEcCtD
Brimonidine—Insomnia—Epirubicin—uterine cancer	0.000758	0.000986	CcSEcCtD
Brimonidine—Tachycardia—Doxorubicin—uterine cancer	0.000757	0.000985	CcSEcCtD
Brimonidine—Skin disorder—Doxorubicin—uterine cancer	0.000753	0.00098	CcSEcCtD
Brimonidine—Paraesthesia—Epirubicin—uterine cancer	0.000752	0.000979	CcSEcCtD
Brimonidine—Dyspnoea—Epirubicin—uterine cancer	0.000747	0.000972	CcSEcCtD
Brimonidine—Somnolence—Epirubicin—uterine cancer	0.000745	0.000969	CcSEcCtD
Brimonidine—Dyspepsia—Epirubicin—uterine cancer	0.000738	0.00096	CcSEcCtD
Brimonidine—Hypotension—Doxorubicin—uterine cancer	0.000724	0.000943	CcSEcCtD
Brimonidine—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000723	0.000941	CcSEcCtD
Brimonidine—Fatigue—Epirubicin—uterine cancer	0.000722	0.00094	CcSEcCtD
Brimonidine—Pain—Epirubicin—uterine cancer	0.000717	0.000933	CcSEcCtD
Brimonidine—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000706	0.000919	CcSEcCtD
Brimonidine—Insomnia—Doxorubicin—uterine cancer	0.000701	0.000913	CcSEcCtD
Brimonidine—Paraesthesia—Doxorubicin—uterine cancer	0.000696	0.000906	CcSEcCtD
Brimonidine—Dyspnoea—Doxorubicin—uterine cancer	0.000691	0.0009	CcSEcCtD
Brimonidine—Somnolence—Doxorubicin—uterine cancer	0.000689	0.000897	CcSEcCtD
Brimonidine—Dyspepsia—Doxorubicin—uterine cancer	0.000682	0.000888	CcSEcCtD
Brimonidine—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000669	0.000871	CcSEcCtD
Brimonidine—Fatigue—Doxorubicin—uterine cancer	0.000668	0.00087	CcSEcCtD
Brimonidine—Pain—Doxorubicin—uterine cancer	0.000663	0.000863	CcSEcCtD
Brimonidine—Hypersensitivity—Epirubicin—uterine cancer	0.000617	0.000803	CcSEcCtD
Brimonidine—Asthenia—Epirubicin—uterine cancer	0.000601	0.000782	CcSEcCtD
Brimonidine—Pruritus—Epirubicin—uterine cancer	0.000593	0.000772	CcSEcCtD
Brimonidine—Hypersensitivity—Doxorubicin—uterine cancer	0.000571	0.000743	CcSEcCtD
Brimonidine—Asthenia—Doxorubicin—uterine cancer	0.000556	0.000724	CcSEcCtD
Brimonidine—Dizziness—Epirubicin—uterine cancer	0.000554	0.000721	CcSEcCtD
Brimonidine—Pruritus—Doxorubicin—uterine cancer	0.000549	0.000714	CcSEcCtD
Brimonidine—Rash—Epirubicin—uterine cancer	0.000528	0.000688	CcSEcCtD
Brimonidine—Dermatitis—Epirubicin—uterine cancer	0.000528	0.000687	CcSEcCtD
Brimonidine—Headache—Epirubicin—uterine cancer	0.000525	0.000683	CcSEcCtD
Brimonidine—Dizziness—Doxorubicin—uterine cancer	0.000513	0.000667	CcSEcCtD
Brimonidine—Nausea—Epirubicin—uterine cancer	0.000498	0.000648	CcSEcCtD
Brimonidine—Rash—Doxorubicin—uterine cancer	0.000489	0.000636	CcSEcCtD
Brimonidine—Dermatitis—Doxorubicin—uterine cancer	0.000488	0.000636	CcSEcCtD
Brimonidine—Headache—Doxorubicin—uterine cancer	0.000486	0.000632	CcSEcCtD
Brimonidine—Nausea—Doxorubicin—uterine cancer	0.000461	0.000599	CcSEcCtD
